Hepatic cytochrome P450 CYP2C activity in psoriasis: studies using proguanil as a probe compound: Investigative reports

Helsby, Nuala A.; Ward, Stephen A.; Parslew, Richard A.; Friedmann, Peter S.; Rhodes, Lesley E.
May 1998
Acta Dermato-Venereologica;5/1/1998, Vol. 78 Issue 2, p81
Academic Journal
Retinol and proguanil are metabolised by the same family of hepatic cytochrome P450, i.e. CYP2C. We used proguanil as a probe to study CYP2C activity, and by implication retinol metabolism, in psoriasis. In vitro studies showed that retinol competitively inhibited the hepatic metabolism of proguanil to cycloguanil. Proguanil metabolism was assessed in 82 patients with chronic plaque psoriasis. Following proguanil orally (200 mg), urine was analysed for proguanil and cycloguanil. A proguanil to cycloguanil ratio <1 signified extensive metabolism and a ratio >10 poor metabolism. A wider range of ratios was observed in psoriasis than previously reported for normal subjects. The proguanil to cycloguanil ratio was assessed in 10 cases each of known severe and mild psoriasis. Low CYP2C activity was associated with severe psoriasis, poor metaboliser status occurring in 50% of the severe group, but in none of the mild cases, p<0.01. These findings may indicate differences in retinoid metabolism in psoriasis.


Related Articles

  • Cytochrome P450 CYP1B1 Interacts with 8-Methoxypsoralen (8-MOP) and Influences Psoralen-Ultraviolet A (PUVA) Sensitivity. Deeni, Yusuf Y.; Ibbotson, Sally H.; Woods, Julie A.; Wolf, C. Roland; Smith, Gillian // PLoS ONE;Sep2013, Vol. 8 Issue 9, p1 

    Background: There are unpredictable inter-individual differences in sensitivity to psoralen-UVA (PUVA) photochemotherapy, used to treat skin diseases including psoriasis. Psoralens are metabolised by cytochrome P450 enzymes (P450), and we hypothesised that variability in cutaneous P450...

  • Cytochrome P450 proteins and potential utilization in biodegradation. Guengerich, F. Peter // Environmental Health Perspectives Supplements;Jun95 Supplement 5, Vol. 103, p25 

    Discusses the potential of cytochrome P450 enzymes in biodegradation technology. High catalytic rates and facile expression in microorganisms; Three-dimensional structures of bacterial cytochrome P450 enzymes; Advantages of random mutagenesis.

  • Cytochrome P450s Potential Catalysts for Asymmetric Olefin Epoxidations. Martinez, Carlos A.; Stewart, Jon D. // Current Organic Chemistry;Mar2000, Vol. 4 Issue 3, p263 

    Cytochrome P450 monooxygenases (P450s; EC catalyze a variety of oxidations, although they are best known for hydroxylations and olefin epoxidations. Such enzymes also might be useful in asymmetric synthesis since different forms accept aromatic polycyclic hydro-carbons, prochiral and...

  • Cytochrome P450 Gene-directed Enzyme Prodrug Therapy (GDEPT) for Cancer. L. Chen; D.J. Waxman // Current Pharmaceutical Design;Jul2002, Vol. 8 Issue 15, p1405 

    Several commonly used cancer chemotherapeutic prodrugs, including cyclophosphamide and ifosfamide, are metabolized in the liver by a cytochrome P450 (CYP)-catalyzed prodrug activation reaction that is required for therapeutic activity. Preclinical studies have shown that the chemosensitivity of...

  • Cytochrome P450 Retinoic Acid 4-Hydroxylase Inhibitors: Potential Agents for Cancer Therapy. Njar, V.C.O. // Mini Reviews in Medicinal Chemistry;Jun2002, Vol. 2 Issue 3, p261 

    Retinoids play a crucial role in cellular differentiation and proliferation of epithelial tissue and their utility in oncology and dermatology is well documented. This mini review focuses on the role of all-trans-retinoic acid (ATRA or RA), the principal endogenous retinoid and its metabolism in...

  • Mechanism-Based Inactivators as Probes of Cytochrome P450 Structure and Function. Kent, Ute M.; Jushchyshyn, Monica I.; Hollenberg, Paul F. // Current Drug Metabolism;Sep2001, Vol. 2 Issue 3, p215 

    The cytochromes P450 superfamily of enzymes is a group of hemeproteins That catalyze the metabolism of an extensive series of compounds including drugs, chemical carcinogens, fatty acids, and steroids. They oxidize substrates ranging in size from ethylene to cyclosporin. Although significant...

  • Editorial. PRAKASH, CHANDRA // Current Drug Metabolism;Sep2009, Vol. 10 Issue 7, p659 

    The article discusses various reports published within the issue, including one on the ADME processes that govern the pharmacokinetics of biotech drugs, one on delineating human cytochrome P450 from structure, function and regulation of Substrate Specificity and Polymorphism, and one on the...

  • Dechlorination mechanisms of chlorinated olefins Van Dyke, R. A. // Environmental Health Perspectives;Dec1977, Vol. 21, p121 

    No abstract available.

  • Drug-Cytokine Interactions: Mechanisms and Clinical Implications. Reiss, W.G.; Piscitelli, S.C. // BioDrugs;1998, Vol. 9 Issue 5, p389 

    The potential for certain cytokines to alter cytochrome P450-mediated drug metabolism was first described over 20 years ago. Since that time, a number of in vitro studies in a variety of models have confirmed those observations and evaluated the possible mechanisms. Although the actual...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics